Camlin Fine Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 ,inter alia, to consider and approve the Un-audited Standalone ....
CAMLINFINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Camlin Fine Sciences has informed the stock exchanges that its Board of Directors will meet on Monday, November 10, 2025. The main agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (Q2 and H1 FY26). No financial figures have been disclosed in this filing — only the meeting date is announced. The company has also noted that the trading window for its equity shares remains closed from October 1, 2025, until 48 hours after these results are publicly released.
This is a routine procedural filing and does not contain any financial numbers, so there is no direct impact on the stock price from this announcement itself. However, it signals that Q2 FY26 results are due on November 10, 2025, which is the next key event for shareholders to watch.